Cheng Y. The Valuation and Strategic Role of Amgen as an Anchor Stock in the Biopharmaceutical Industry Under Market Volatility. JID [Internet]. 2025 Nov. 6 [cited 2026 Jul. 5];13(1):294-300. Available from: https://drpress.org/ojs/index.php/jid/article/view/32259